Head to Head Review: Bioceres Crop Solutions (BIOX) versus Its Rivals

Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) is one of 295 public companies in the “Chemicals” industry, but how does it contrast to its rivals? We will compare Bioceres Crop Solutions to similar businesses based on the strength of its risk, institutional ownership, valuation, analyst recommendations, earnings, profitability and dividends.

Institutional & Insider Ownership

17.7% of Bioceres Crop Solutions shares are owned by institutional investors. Comparatively, 47.5% of shares of all “Chemicals” companies are owned by institutional investors. 2.3% of Bioceres Crop Solutions shares are owned by insiders. Comparatively, 13.9% of shares of all “Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Bioceres Crop Solutions and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bioceres Crop Solutions 1 1 0 0 1.50
Bioceres Crop Solutions Competitors 3241 12199 14118 516 2.40

Bioceres Crop Solutions presently has a consensus price target of $2.00, indicating a potential upside of 841.18%. As a group, “Chemicals” companies have a potential upside of 6.46%. Given Bioceres Crop Solutions’ higher possible upside, equities research analysts plainly believe Bioceres Crop Solutions is more favorable than its rivals.

Earnings & Valuation

This table compares Bioceres Crop Solutions and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Bioceres Crop Solutions $238.30 million -$54.40 million -0.06
Bioceres Crop Solutions Competitors $7.98 billion $222.31 million -0.66

Bioceres Crop Solutions’ rivals have higher revenue and earnings than Bioceres Crop Solutions. Bioceres Crop Solutions is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Volatility and Risk

Bioceres Crop Solutions has a beta of 0.54, suggesting that its share price is 46% less volatile than the S&P 500. Comparatively, Bioceres Crop Solutions’ rivals have a beta of 0.93, suggesting that their average share price is 7% less volatile than the S&P 500.

Profitability

This table compares Bioceres Crop Solutions and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bioceres Crop Solutions -94.76% -39.11% -9.45%
Bioceres Crop Solutions Competitors -59.66% 0.26% -1.43%

Summary

Bioceres Crop Solutions rivals beat Bioceres Crop Solutions on 11 of the 12 factors compared.

About Bioceres Crop Solutions

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.